Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sadzot-Delvaux, C.
Right arrow Articles by Rentier, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sadzot-Delvaux, C.
Right arrow Articles by Rentier, B.
NEUROLOGY 1995;45:S18-S20
© 1995 American Academy of Neurology

Varicella-zoster virus latency in the adult rat is a useful model for human latent infection

C. Sadzot-Delvaux, PhD, S. Debrus, MSc, A. Nikkels, MD, J. Piette, PhD, DSc and B. Rentier, PhD, DSc

From the Laboratory of Virology, Department of Microbiology, Institute of Pathology, University of Liege, Belgium.
Address correspondence and reprint requests to Dr. B. Rentier, Laboratory of Virology, Department of Microbiology, Institute of Pathology B23, University of Liege, B-4000 Liege, Belgium.

A model of latent infection by varicella-zoster virus (VZV) was obtained in the adult rat. Inoculation of VZV-infected cells in the skin led to infection of the peripheral nervous system. Latency was characterized by a long-lasting presence of the viral genome, of selected viral gene transcripts, and of at least one viral protein in the dorsal root ganglia. Reactivation has not been obtained in vivo, but has occurred ex vivo after repeated stresses. Many similarities with VZV latency in humans were found, making this model useful for vaccine and antiviral studies.

NEUROLOGY 1995;45(Suppl 8): S18-S20







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by AAN Enterprises, Inc.